Label-Free, Impedance-Based Biosensor for Kidney Disease Biomarker Uromodulin

We demonstrate the development of a label-free, impedance-based biosensor by using a passivation layer of 50-nm tantalum pentoxide (Ta<sub>2</sub>O<sub>5</sub>) on interdigitated electrodes (IDE). This layer was fabricated by atomic layer deposition (ALD) and has a high diele...

Full description

Bibliographic Details
Main Authors: Kunj Vora, Norbert Kordas, Karsten Seidl
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/23/24/9696
Description
Summary:We demonstrate the development of a label-free, impedance-based biosensor by using a passivation layer of 50-nm tantalum pentoxide (Ta<sub>2</sub>O<sub>5</sub>) on interdigitated electrodes (IDE). This layer was fabricated by atomic layer deposition (ALD) and has a high dielectric constant (high-<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi>κ</mi></semantics></math></inline-formula>), which improves the capacitive property of the IDE. We validate the biosensor’s performance by measuring uromodulin, a urine biomarker for kidney tubular damage, from artificial urine samples. The passivation layer is functionalized with uromodulin antibodies for selective binding. The passivated IDE enables the non-faradaic impedance measurement of uromodulin concentrations with a measurement range from 0.5 ng/mL to 8 ng/mL and with a relative change in impedance of 15 % per ng/mL at a frequency of 150 Hz (log scale). This work presents a concept for point-of-care biosensing applications for disease biomarkers.
ISSN:1424-8220